危重成人体外膜氧合后的长期死亡率与功能结局:系统评价与Meta分析
该系统评价与Meta分析纳入163项研究共78,053例接受ECMO的危重成人,其中59,454例(156项研究)纳入死亡率合并分析。1年合并死亡率:VV-ECMO为37.2%(95%CI 30.0-45.1%),VA-ECMO为55.2%(95%CI 50.2-60.1%),ECPR为74.4%(95%CI 71.4-77.2%)。仅38项研究(23.3%)报告了7,876例存活者的功能结局,且评估工具异质(最常用CPC、WHODAS 2.0、mRS)。作者结论:ECMO长期死亡因模式而异,功能结局报告不统一,需标准化报告与基准化以指导长期预后和患者选择。
要点
- 危重成人ECMO后1年合并死亡率因模式不同:VV-ECMO 37.2%(95%CI 30.0-45.1%),VA-ECMO 55.2%(95%CI 50.2-60.1%),ECPR 74.4%(95%CI 71.4-77.2%)。
- 该Meta分析纳入163项研究共78,053例成人,其中59,454例(95.7%)贡献死亡率数据,来源为RCT和观察性研究。
- 功能结局仅38项研究(23.3%)报告,涉及7,876例存活者,评估工具异质,最常用CPC(52.6%)、WHODAS 2.0(13.2%)、mRS(13.2%)。
- 功能结局因异质性仅作叙述性合成,无法合并,限制了对存活者功能恢复的理解。
- 作者呼吁标准化报告和基准化,以更好指导长期预后、患者选择及改善功能恢复的因素。
适用人群与场景
- 接受ECMO治疗的危重成人,纳入报告≥6个月死亡率或功能结局的RCT和观察性研究;排除标准原文未提及。
- 场景为成人ECMO治疗后的长期随访,非急诊/ICU急性期决策场景。
诊断标准与关键阈值
- 纳入标准:RCT或观察性研究,报告成人ECMO后≥6个月的死亡率或功能结局。
- 功能评估工具包括脑功能分类(CPC)、WHO残疾评定方案2.0(WHODAS 2.0)、改良Rankin量表(mRS)。
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型:系统评价与Meta分析,纳入163项研究共78,053例成人,其中156项研究59,454例(95.7%)纳入死亡率合并分析。
- 1年合并死亡率:VV-ECMO 37.2%(95%CI 30.0-45.1%,13/33项研究);VA-ECMO 55.2%(95%CI 50.2-60.1%,42/55项研究);ECPR 74.4%(95%CI 71.4-77.2%,14/24项研究)。
- 功能结局:38/163项研究(23.3%)报告7,876例存活者,评估工具异质,最常用CPC(20/38,52.6%)、WHODAS 2.0(5/38,13.2%)、mRS(5/38,13.2%)。
- 功能结局因异质性仅作叙述性合成,未合并。
证据类型、等级与局限
- 证据类型:系统评价与Meta分析,遵循PRISMA 2020,PROSPERO注册号CRD420251002639。
- 纳入RCT和观察性研究,证据等级原文未提及。
- 局限:功能结局报告不一致且异质,仅叙述性合成;原文未提及其他局限。
对床旁实践的改变
- 该研究提示ECMO长期死亡因模式而异,可辅助与家属沟通长期预后,但功能结局数据有限且不统一。
- 不改变急性期ECMO适应证或管理决策;适用人群为接受ECMO的危重成人,不适用于非ECMO患者。
- 常见陷阱:将合并死亡率误作单个患者精确预测,或忽略功能结局报告的高度异质性。
指南或共识出处
- 原文未提及具体指南或共识名称;系统评价注册于PROSPERO(CRD420251002639)。
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate long-term all-cause mortality and functional outcomes among critically ill adults treated with extracorporeal membrane oxygenation (ECMO), including differences by ECMO modality and clinical indication.
DATA SOURCES: Ovid MEDLINE, Embase, Emcare, Central Register of Controlled Trials, and Scopus were searched to March 2025.
STUDY SELECTION: Randomized controlled trials and observational studies reporting mortality or functional outcomes at or beyond 6 months in adults receiving ECMO were eligible for inclusion.
DATA EXTRACTION: A systematic review and meta-analysis were conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines and prospectively registered with PROSPERO (CRD420251002639). Two reviewers independently extracted data. Mortality was pooled using random-effects meta-analysis with 95% CIs. Prespecified subgroup analyses examined ECMO modality and clinical indication. Sensitivity analyses assessed the impact of missing outcome data. Functional outcomes were narratively synthesized due to heterogeneity.
DATA SYNTHESIS: A total of 163 studies including 78,053 adults met inclusion criteria, with 59,454 adults in 156 of 163 studies (95.7%) contributing to mortality meta-analyses. At 1 year, pooled mortality was 37.2% (95% CI, 30.0-45.1%) in 13 of 33 venovenous ECMO studies (39.4%), 55.2% (95% CI, 50.2-60.1%) in 42 of 55 venoarterial ECMO studies (76.4%), and 74.4% (95% CI, 71.4-77.2%) in 14 of 24 (58.3%) extracorporeal cardiopulmonary resuscitation (ECPR) studies. Functional outcomes were reported in 38 of 163 studies (23.3%) in 7,876 survivors and were assessed using various instruments, most commonly the Cerebral Performance Category in 20 of 38 studies (52.6%), the World Health Organization Disability Assessment Schedule 2.0 in five of 38 studies (13.2%), and the modified Rankin Scale in five of 38 studies (13.2%).
CONCLUSIONS: Long-term mortality following ECMO differed substantially by ECMO modality, ranging from 37.2% among adults receiving venovenous ECMO to 74.4% among adults receiving ECPR. Functional outcomes were inconsistently reported, limiting the understanding of functional recovery among survivors. Standardized reporting and benchmarking are required to better inform long-term prognosis, patient selection, and factors that may improve functional recovery after ECMO.
参考来源
- Stebbins KT, Yap CY, Segun-Beloved L, et al. Long-Term Mortality and Functional Outcomes After Extracorporeal Membrane Oxygenation in Critically Ill Adults: A Systematic Review and Meta-Analysis. Crit Care Med. 2026. PMID: 42671261. doi:10.1097/CCM.0000000000007318
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。